Blocking a cellular stress pathway may help preserve insulin-producing cells

by Weill Cornell Medical College

edited by Gaby Clark, reviewed by Andrew Zinin

Gaby Clark

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add to Preferred Sources

Researchers at Weill Cornell Medicine have identified a molecular pathway that contributes to the death of insulin-producing beta cells in the pancreas. Experiments with preclinical models and human pancreatic cells found that blocking certain proteins in the pathway helped protect beta cells from excessive cellular stress. The discovery, recently published in the Journal of Clinical Investigation, suggests a new strategy to preserve the cells that regulate blood sugar and potentially treat type 2 diabetes.

Diabetes is a complex, chronic disease with two forms. In type 1, the immune system attacks and destroys beta cells, leaving the body with little or no insulin. In type 2, the body's cells become less responsive to insulin, so beta cells must churn out more of the hormone to keep blood sugar in check. Over time, beta cells can become dysfunctional and some are lost through cell death, further compromising insulin production.

"The goal of this study was to understand the molecular pathways that cause overworked beta cells to die," said senior author Dr. Laura Alonso, chief of the division of endocrinology, diabetes and metabolism, director of the Weill Center for Metabolic Health and the E. Hugh Luckey Distinguished Professor in Medicine at Weill Cornell.

Stress response in overdrive

The researchers suspected the loss of overtaxed beta cells might involve the unfolded protein response (UPR)—a cellular system that helps cells cope when proteins accumulate faster than they can be properly processed. The UPR pathway temporarily adjusts protein production and triggers molecular chaperones, which help proteins fold correctly.

With collaborator Dr. Amy Lee of the University of Southern California, the team created mice whose beta cells lacked GRP78, a protein that keeps the UPR pathways in check under normal conditions. The effect was dramatic. Without GRP78, the beta cells' stress response kicks into overdrive and cells start to die. "By two weeks of age, the beta cells were starting to be lost, and by four weeks after birth, the mice were diabetic," said Alonso.

Although the UPR is meant to help beta cells produce and process insulin, keeping the pathway continuously activated is ultimately fatal.

Inhibitors to the rescue

With their sights set on the UPR, the researchers cataloged the genes and proteins with altered levels when GRP78 is missing. They found three proteins were significantly activated: IRE1α, JNK and p53. The findings suggest that excessive activation of the stress response triggered a signaling cascade in which IRE1α activates JNK, which in turn leads to p53 activation, helping trigger beta cell death.

Treating mice that lack GRP78 with a JNK inhibitor significantly reduced beta cell death. The treatment also protected beta cells in a second mouse model of diabetes, in which a mutation in the insulin gene causes misfolded insulin to accumulate and stress the cells.

The researchers—including first author Dr. Rohit Sharma, an assistant professor of molecular biology in medicine at Weill Cornell—saw a similar protective effect when treating donated human pancreatic islet cells. When GRP78 levels in these cells were reduced, inhibiting either JNK or p53 helped prevent human beta cell death.

"Preserving beta cell mass is a really important goal in diabetes research," said Alonso. "If we could safely administer a JNK or p53 inhibitor, we might be able to preserve the ability of beta cells to produce insulin and stave off diabetes."

Further research will be necessary to find a suitable JNK inhibitor for clinical use since the one used in the experiments acts on multiple forms of JNK and can damage kidney function.

"I would love to have a new drug to help preserve beta cells in my patients today," said Alonso, who is also an endocrinologist at NewYork-Presbyterian/Weill Cornell Medical Center. But for now, Alonso and her team will continue pursuing the molecular causes of beta cell death.

Her lab plans to test whether JNK inhibition protects beta cells in other models of diabetes, such as type 2 diabetes brought on by a high-fat diet. She would also like to explore if a combination of JNK and p53 inhibitors better minimizes cell death and normalizes blood sugar.

Publication details

Rohit B. Sharma et al., JNK and p53 cause human and mouse β cell death during excessive unfolded protein response, Journal of Clinical Investigation (2026). DOI: 10.1172/jci193035

Journal information: Journal of Clinical Investigation

Key medical concepts

Unfolded Protein ResponseSAPK1TP53 protein, human

Clinical categories

Endocrinology Provided by Weill Cornell Medical College Who's behind this story?

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Blocking a cellular stress pathway may help preserve insulin-producing cells (2026, October 21) retrieved 22 October 2026 from https://medicalxpress.com/news/2026-10-blocking-cellular-stress-pathway-insulin.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.